Subject Accession	Species	Race	Race Specify	Ethnicity	Strain	Gender	Age Event	Age Event Specify	Subject Age	Age Unit	Subject Phenotype	ARM Accession	ARM Name	Study Accession	Study Brief Title	Biosample Accession	Biosample Description	Biosample Name	Biosample Type	Biosample Subtype	Study Time Collected	Study Time Collected Unit	Study Time T0 Event	Study Time T0 Event Specify	Biosample Treatment	Planned Visit Accession	Planned Visit Name	Experiment Accession	Expsample Accession	Expsample Description	Expsample Result Schema	Expsample Treatement	Reagent Accession	Reagent Name	Reagent Reporter Name	File Info ID	File Detail	File Name	Original File Name
SUB116449	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		69.4	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740991			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES804997	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116449	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		69.4	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740991			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES804997	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504092	CyTOF result	090712-Mike-Study 15-2011-15007_cells_found.504092.fcs	090712-Mike-Study 15-2011-15007_cells_found.fcs
SUB116515	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		74.3	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741054			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805060	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116515	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		74.3	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741054			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805060	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504155	CyTOF result	083012-Mike-Study 15-2011-V1-15099_cells_found.504155.fcs	083012-Mike-Study 15-2011-V1-15099_cells_found.fcs
SUB116516	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		85.7	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741055			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805061	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116516	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		85.7	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741055			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805061	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504156	CyTOF result	082812-Mike-Study 15-2011-15100_cells_found.504156.fcs	082812-Mike-Study 15-2011-15100_cells_found.fcs
SUB116518	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		75.4	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741057			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805063	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116518	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		75.4	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741057			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805063	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504158	CyTOF result	083012-Mike-Study 15-2011-V1-15102_cells_found.504158.fcs	083012-Mike-Study 15-2011-V1-15102_cells_found.fcs
SUB116519	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		25.4	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741058			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805064	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116519	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		25.4	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741058			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805064	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504159	CyTOF result	083012-Mike-Study 15-2011-V1-15103_cells_found.504159.fcs	083012-Mike-Study 15-2011-V1-15103_cells_found.fcs
SUB116520	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		79.1	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741059			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805065	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116520	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		79.1	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741059			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805065	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504160	CyTOF result	090512-Study 15-2011-15104_cells_found.504160.fcs	090512-Study 15-2011-15104_cells_found.fcs
SUB116521	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		85.6	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741060			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805066	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116521	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		85.6	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741060			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805066	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504161	CyTOF result	083012-Mike-Study 15-2011-V1-15105_cells_found.504161.fcs	083012-Mike-Study 15-2011-V1-15105_cells_found.fcs
SUB116522	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		83.5	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741061			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805067	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116522	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		83.5	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741061			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805067	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504162	CyTOF result	083012-Mike-Study 15-2011-V1-15106_cells_found.504162.fcs	083012-Mike-Study 15-2011-V1-15106_cells_found.fcs
SUB116523	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		26.5	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741062			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805068	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116523	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		26.5	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741062			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805068	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504163	CyTOF result	083012-Mike-Study 15-2011-V1-15107_cells_found.504163.fcs	083012-Mike-Study 15-2011-V1-15107_cells_found.fcs
SUB116524	Homo sapiens	White		Hispanic or Latino		Male	Age at Study Day 0		29.2	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741063			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805069	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116524	Homo sapiens	White		Hispanic or Latino		Male	Age at Study Day 0		29.2	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741063			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805069	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504164	CyTOF result	083012-Mike-Study 15-2011-V1-15108_cells_found.504164.fcs	083012-Mike-Study 15-2011-V1-15108_cells_found.fcs
SUB116525	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at Study Day 0		28	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741064			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805070	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116525	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at Study Day 0		28	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741064			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805070	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504165	CyTOF result	083012-Mike-Study 15-2011-V1-15109_cells_found.504165.fcs	083012-Mike-Study 15-2011-V1-15109_cells_found.fcs
SUB116526	Homo sapiens	Other	White,Asian	Not Hispanic or Latino		Female	Age at Study Day 0		20.5	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741065			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805071	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116526	Homo sapiens	Other	White,Asian	Not Hispanic or Latino		Female	Age at Study Day 0		20.5	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741065			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805071	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504166	CyTOF result	083012-Mike-Study 15-2011-V1-15110_cells_found.504166.fcs	083012-Mike-Study 15-2011-V1-15110_cells_found.fcs
SUB116527	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		27.1	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741066			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805072	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116527	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		27.1	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741066			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805072	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504167	CyTOF result	083012-Mike-Study 15-2011-V1-15111_cells_found.504167.fcs	083012-Mike-Study 15-2011-V1-15111_cells_found.fcs
SUB116528	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		27	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741067			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805073	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116528	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		27	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741067			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805073	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504168	CyTOF result	083012-Mike-Study 15-2011-V1-15112_cells_found.504168.fcs	083012-Mike-Study 15-2011-V1-15112_cells_found.fcs
SUB116529	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at Study Day 0		24.8	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741068			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805074	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116529	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at Study Day 0		24.8	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741068			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805074	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504169	CyTOF result	083012-Mike-Study 15-2011-V1-15113_cells_found.504169.fcs	083012-Mike-Study 15-2011-V1-15113_cells_found.fcs
SUB116530	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		25.8	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741069			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805075	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116530	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		25.8	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741069			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805075	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504170	CyTOF result	083012-Mike-Study 15-2011-V1-15114_cells_found.504170.fcs	083012-Mike-Study 15-2011-V1-15114_cells_found.fcs
SUB116531	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at Study Day 0		24.1	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741070			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805076	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116531	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at Study Day 0		24.1	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741070			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805076	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504171	CyTOF result	083012-Mike-Study 15-2011-V1-15115_cells_found.504171.fcs	083012-Mike-Study 15-2011-V1-15115_cells_found.fcs
SUB116532	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at Study Day 0		21.4	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741071			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805077	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116532	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at Study Day 0		21.4	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741071			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805077	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504172	CyTOF result	083012-Mike-Study 15-2011-V1-15118_cells_found.504172.fcs	083012-Mike-Study 15-2011-V1-15118_cells_found.fcs
SUB116533	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		76.1	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741072			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805078	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116533	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		76.1	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741072			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805078	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504173	CyTOF result	083012-Mike-Study 15-2011-V1-15119_cells_found.504173.fcs	083012-Mike-Study 15-2011-V1-15119_cells_found.fcs
SUB116534	Homo sapiens	White		Hispanic or Latino		Female	Age at Study Day 0		30.6	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741073			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805079	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116534	Homo sapiens	White		Hispanic or Latino		Female	Age at Study Day 0		30.6	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741073			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805079	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504174	CyTOF result	090512-Study 15-2011-15120_cells_found.504174.fcs	090512-Study 15-2011-15120_cells_found.fcs
SUB116535	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at Study Day 0		25	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741074			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805080	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116535	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at Study Day 0		25	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741074			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805080	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504175	CyTOF result	083012-Mike-Study 15-2011-V1-15121_cells_found.504175.fcs	083012-Mike-Study 15-2011-V1-15121_cells_found.fcs
SUB116536	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at Study Day 0		29.5	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741075			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805081	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116536	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at Study Day 0		29.5	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741075			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805081	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504176	CyTOF result	090512-Study 15-2011-15122_cells_found.504176.fcs	090512-Study 15-2011-15122_cells_found.fcs
SUB116537	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		24.5	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741076			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805082	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB116537	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		24.5	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741076			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805082	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504177	CyTOF result	090512-Study 15-2011-15123_cells_found.504177.fcs	090512-Study 15-2011-15123_cells_found.fcs
SUB118135	Homo sapiens	Other	Other	Other		Male	Age at Study Day 0	NA	0	Years	EXP_CONTROL	ARM2209	CyTOF technical control samples	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741077			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805083	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB118135	Homo sapiens	Other	Other	Other		Male	Age at Study Day 0	NA	0	Years	EXP_CONTROL	ARM2209	CyTOF technical control samples	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741077			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805083	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504178	CyTOF result	081712-Mike-Study 15-2011-885 control-2_cells_found.504178.fcs	081712-Mike-Study 15-2011-885 control-2_cells_found.fcs
SUB118135	Homo sapiens	Other	Other	Other		Male	Age at Study Day 0	NA	0	Years	EXP_CONTROL	ARM2209	CyTOF technical control samples	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741077			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805084	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB118135	Homo sapiens	Other	Other	Other		Male	Age at Study Day 0	NA	0	Years	EXP_CONTROL	ARM2209	CyTOF technical control samples	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741077			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805084	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504179	CyTOF result	082812-Mike-Study 15-2011-885 control-4_cells_found.504179.fcs	082812-Mike-Study 15-2011-885 control-4_cells_found.fcs
SUB118135	Homo sapiens	Other	Other	Other		Male	Age at Study Day 0	NA	0	Years	EXP_CONTROL	ARM2209	CyTOF technical control samples	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741077			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805085	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB118135	Homo sapiens	Other	Other	Other		Male	Age at Study Day 0	NA	0	Years	EXP_CONTROL	ARM2209	CyTOF technical control samples	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741077			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805085	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504180	CyTOF result	083012-Mike-Study 15-2011-V1-885 control-5_cells_found.504180.fcs	083012-Mike-Study 15-2011-V1-885 control-5_cells_found.fcs
SUB118135	Homo sapiens	Other	Other	Other		Male	Age at Study Day 0	NA	0	Years	EXP_CONTROL	ARM2209	CyTOF technical control samples	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741077			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805086	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB118135	Homo sapiens	Other	Other	Other		Male	Age at Study Day 0	NA	0	Years	EXP_CONTROL	ARM2209	CyTOF technical control samples	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741077			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805086	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504181	CyTOF result	090512-Study 15-2011-885 control-5a_cells_found.504181.fcs	090512-Study 15-2011-885 control-5a_cells_found.fcs
SUB118135	Homo sapiens	Other	Other	Other		Male	Age at Study Day 0	NA	0	Years	EXP_CONTROL	ARM2209	CyTOF technical control samples	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741077			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805087	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB118135	Homo sapiens	Other	Other	Other		Male	Age at Study Day 0	NA	0	Years	EXP_CONTROL	ARM2209	CyTOF technical control samples	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741077			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805087	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504182	CyTOF result	090712-Mike-Study 15-2011-885 control-6_cells_found.504182.fcs	090712-Mike-Study 15-2011-885 control-6_cells_found.fcs
SUB118135	Homo sapiens	Other	Other	Other		Male	Age at Study Day 0	NA	0	Years	EXP_CONTROL	ARM2209	CyTOF technical control samples	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741077			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805088	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB118135	Homo sapiens	Other	Other	Other		Male	Age at Study Day 0	NA	0	Years	EXP_CONTROL	ARM2209	CyTOF technical control samples	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741077			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805088	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504183	CyTOF result	090512-Study 15-2011-885-post_cells_found.504183.fcs	090512-Study 15-2011-885-post_cells_found.fcs
SUB118135	Homo sapiens	Other	Other	Other		Male	Age at Study Day 0	NA	0	Years	EXP_CONTROL	ARM2209	CyTOF technical control samples	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741077			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805089	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB118135	Homo sapiens	Other	Other	Other		Male	Age at Study Day 0	NA	0	Years	EXP_CONTROL	ARM2209	CyTOF technical control samples	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741077			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805089	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504184	CyTOF result	090512-Study 15-2011-885cct.504184.fcs	090512-Study 15-2011-885cct.fcs
SUB134239	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		64.9	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740989			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES804995	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504089	CyTOF result	090712-Mike-Study 15-2011-15004_cells_found.504089.fcs	090712-Mike-Study 15-2011-15004_cells_found.fcs
SUB134239	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		64.9	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740989			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES804995	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134240	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		65.9	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740990			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES804996	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134240	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		65.9	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740990			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES804996	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504091	CyTOF result	090712-Mike-Study 15-2011-15006_cells_found.504091.fcs	090712-Mike-Study 15-2011-15006_cells_found.fcs
SUB134242	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		29.9	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740992			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES804998	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134242	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		29.9	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740992			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES804998	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504093	CyTOF result	090712-Mike-Study 15-2011-15010_cells_found.504093.fcs	090712-Mike-Study 15-2011-15010_cells_found.fcs
SUB134243	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		68.9	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740993			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES804999	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134243	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		68.9	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740993			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES804999	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504094	CyTOF result	090712-Mike-Study 15-2011-15011_cells_found.504094.fcs	090712-Mike-Study 15-2011-15011_cells_found.fcs
SUB134244	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		66.7	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740994			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805000	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134244	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		66.7	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740994			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805000	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504095	CyTOF result	090712-Mike-Study 15-2011-15012_cells_found.504095.fcs	090712-Mike-Study 15-2011-15012_cells_found.fcs
SUB134245	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		68.6	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740995			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805001	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134245	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		68.6	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740995			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805001	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504096	CyTOF result	090712-Mike-Study 15-2011-15013_cells_found.504096.fcs	090712-Mike-Study 15-2011-15013_cells_found.fcs
SUB134246	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		78.1	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740996			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805002	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134246	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		78.1	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740996			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805002	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504097	CyTOF result	090712-Mike-Study 15-2011-15014_cells_found.504097.fcs	090712-Mike-Study 15-2011-15014_cells_found.fcs
SUB134247	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		65.4	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740997			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805003	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134247	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		65.4	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740997			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805003	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504098	CyTOF result	090712-Mike-Study 15-2011-15015_cells_found.504098.fcs	090712-Mike-Study 15-2011-15015_cells_found.fcs
SUB134248	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		64.6	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740998			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805004	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134248	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		64.6	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740998			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805004	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504099	CyTOF result	090712-Mike-Study 15-2011-15016_cells_found.504099.fcs	090712-Mike-Study 15-2011-15016_cells_found.fcs
SUB134249	Homo sapiens	Other	North African	Not Hispanic or Latino		Female	Age at Study Day 0		29.1	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740999			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805005	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134249	Homo sapiens	Other	North African	Not Hispanic or Latino		Female	Age at Study Day 0		29.1	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS740999			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805005	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504100	CyTOF result	090512-Study 15-2011-15018_cells_found.504100.fcs	090512-Study 15-2011-15018_cells_found.fcs
SUB134250	Homo sapiens	Other	White, Asian	Not Hispanic or Latino		Female	Age at Study Day 0		27.8	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741000			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805006	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134250	Homo sapiens	Other	White, Asian	Not Hispanic or Latino		Female	Age at Study Day 0		27.8	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741000			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805006	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504101	CyTOF result	090512-Study 15-2011-15019_cells_found.504101.fcs	090512-Study 15-2011-15019_cells_found.fcs
SUB134251	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		32.2	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741001			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805007	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134251	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		32.2	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741001			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805007	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504102	CyTOF result	090712-Mike-Study 15-2011-15020_cells_found.504102.fcs	090712-Mike-Study 15-2011-15020_cells_found.fcs
SUB134252	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at Study Day 0		27.2	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741002			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805008	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134252	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at Study Day 0		27.2	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741002			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805008	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504103	CyTOF result	090712-Mike-Study 15-2011-15021_cells_found.504103.fcs	090712-Mike-Study 15-2011-15021_cells_found.fcs
SUB134253	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at Study Day 0		25.7	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741003			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805009	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134253	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at Study Day 0		25.7	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741003			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805009	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504104	CyTOF result	090712-Mike-Study 15-2011-15022_cells_found.504104.fcs	090712-Mike-Study 15-2011-15022_cells_found.fcs
SUB134254	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		88	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741004			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805010	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134254	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		88	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741004			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805010	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504105	CyTOF result	090512-Study 15-2011-15023_cells_found.504105.fcs	090512-Study 15-2011-15023_cells_found.fcs
SUB134255	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		87.5	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741005			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805011	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134255	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		87.5	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741005			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805011	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504106	CyTOF result	090712-Mike-Study 15-2011-15024_cells_found.504106.fcs	090712-Mike-Study 15-2011-15024_cells_found.fcs
SUB134256	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		86.9	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741006			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805012	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134256	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		86.9	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741006			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805012	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504107	CyTOF result	090512-Study 15-2011-15025_cells_found.504107.fcs	090512-Study 15-2011-15025_cells_found.fcs
SUB134257	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		87.6	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741007			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805013	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134257	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		87.6	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741007			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805013	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504108	CyTOF result	081712-Mike-Study 15-2011-15026_cells_found.504108.fcs	081712-Mike-Study 15-2011-15026_cells_found.fcs
SUB134258	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		88.4	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741008			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805014	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134258	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		88.4	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741008			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805014	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504109	CyTOF result	081712-Mike-Study 15-2011-15028_cells_found.504109.fcs	081712-Mike-Study 15-2011-15028_cells_found.fcs
SUB134259	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		88.8	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741009			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805015	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134259	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		88.8	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741009			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805015	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504110	CyTOF result	081712-Mike-Study 15-2011-15029_cells_found.504110.fcs	081712-Mike-Study 15-2011-15029_cells_found.fcs
SUB134260	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		68.5	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741010			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805016	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134260	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		68.5	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741010			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805016	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504111	CyTOF result	081712-Mike-Study 15-2011-15031_cells_found.504111.fcs	081712-Mike-Study 15-2011-15031_cells_found.fcs
SUB134261	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		81.8	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741011			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805017	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134261	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		81.8	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741011			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805017	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504112	CyTOF result	081712-Mike-Study 15-2011-15032_cells_found.504112.fcs	081712-Mike-Study 15-2011-15032_cells_found.fcs
SUB134262	Homo sapiens	American Indian or Alaska Native		Not Hispanic or Latino		Male	Age at Study Day 0		87.2	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741012			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805018	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134262	Homo sapiens	American Indian or Alaska Native		Not Hispanic or Latino		Male	Age at Study Day 0		87.2	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741012			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805018	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504113	CyTOF result	081712-Mike-Study 15-2011-15033_cells_found.504113.fcs	081712-Mike-Study 15-2011-15033_cells_found.fcs
SUB134263	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		76.1	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741013			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805019	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134263	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		76.1	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741013			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805019	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504114	CyTOF result	081712-Mike-Study 15-2011-15034_cells_found.504114.fcs	081712-Mike-Study 15-2011-15034_cells_found.fcs
SUB134264	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		71.2	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741014			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805020	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134264	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		71.2	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741014			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805020	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504115	CyTOF result	081712-Mike-Study 15-2011-15035_cells_found.504115.fcs	081712-Mike-Study 15-2011-15035_cells_found.fcs
SUB134265	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		88.9	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741015			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805021	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134265	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		88.9	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741015			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805021	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504116	CyTOF result	081712-Mike-Study 15-2011-15036_cells_found.504116.fcs	081712-Mike-Study 15-2011-15036_cells_found.fcs
SUB134266	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		78.3	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741016			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805022	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134266	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		78.3	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741016			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805022	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504117	CyTOF result	081712-Mike-Study 15-2011-15037_cells_found.504117.fcs	081712-Mike-Study 15-2011-15037_cells_found.fcs
SUB134267	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741017			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805023	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134267	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741017			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805023	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504118	CyTOF result	081712-Mike-Study 15-2011-15038_cells_found.504118.fcs	081712-Mike-Study 15-2011-15038_cells_found.fcs
SUB134269	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		74.8	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741018			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805024	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134269	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		74.8	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741018			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805024	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504119	CyTOF result	081712-Mike-Study 15-2011-15040b_cells_found.504119.fcs	081712-Mike-Study 15-2011-15040b_cells_found.fcs
SUB134270	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		69.6	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741019			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805025	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134270	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		69.6	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741019			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805025	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504120	CyTOF result	081712-Mike-Study 15-2011-15041_cells_found.504120.fcs	081712-Mike-Study 15-2011-15041_cells_found.fcs
SUB134272	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		75.6	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741020			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805026	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134272	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		75.6	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741020			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805026	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504121	CyTOF result	081712-Mike-Study 15-2011-15044_cells_found.504121.fcs	081712-Mike-Study 15-2011-15044_cells_found.fcs
SUB134273	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		71.5	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741021			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805027	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134273	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		71.5	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741021			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805027	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504122	CyTOF result	081712-Mike-Study 15-2011-15045_cells_found.504122.fcs	081712-Mike-Study 15-2011-15045_cells_found.fcs
SUB134274	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		83.7	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741022			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805028	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134274	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		83.7	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741022			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805028	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504123	CyTOF result	081712-Mike-Study 15-2011-15046_cells_found.504123.fcs	081712-Mike-Study 15-2011-15046_cells_found.fcs
SUB134276	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741023			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805029	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134276	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741023			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805029	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504124	CyTOF result	081712-Mike-Study 15-2011-15048_cells_found.504124.fcs	081712-Mike-Study 15-2011-15048_cells_found.fcs
SUB134278	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		86.5	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741024			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805030	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134278	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		86.5	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741024			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805030	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504125	CyTOF result	081712-Mike-Study 15-2011-15050b_cells_found.504125.fcs	081712-Mike-Study 15-2011-15050b_cells_found.fcs
SUB134279	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		65.7	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741025			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805031	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134279	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		65.7	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741025			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805031	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504126	CyTOF result	090512-Study 15-2011-15051_cells_found.504126.fcs	090512-Study 15-2011-15051_cells_found.fcs
SUB134280	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		80.3	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741026			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805032	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134280	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		80.3	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741026			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805032	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504127	CyTOF result	090512-Study 15-2011-15052_cells_found.504127.fcs	090512-Study 15-2011-15052_cells_found.fcs
SUB134281	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		81.6	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741027			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805033	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134281	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		81.6	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741027			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805033	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504128	CyTOF result	090512-Study 15-2011-15053_cells_found.504128.fcs	090512-Study 15-2011-15053_cells_found.fcs
SUB134283	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		87.6	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741028			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805034	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134283	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		87.6	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741028			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805034	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504129	CyTOF result	090512-Study 15-2011-15055_cells_found.504129.fcs	090512-Study 15-2011-15055_cells_found.fcs
SUB134286	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		69.6	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741029			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805035	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134286	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		69.6	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741029			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805035	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504130	CyTOF result	090712-Mike-Study 15-2011-15058_cells_found.504130.fcs	090712-Mike-Study 15-2011-15058_cells_found.fcs
SUB134288	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		86.9	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741030			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805036	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134288	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		86.9	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741030			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805036	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504131	CyTOF result	090512-Study 15-2011-15060_cells_found.504131.fcs	090512-Study 15-2011-15060_cells_found.fcs
SUB134289	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		76.2	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741031			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805037	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134289	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		76.2	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741031			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805037	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504132	CyTOF result	090512-Study 15-2011-15061_cells_found.504132.fcs	090512-Study 15-2011-15061_cells_found.fcs
SUB134292	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		71.9	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741032			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805038	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134292	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		71.9	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741032			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805038	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504133	CyTOF result	082812-Mike-Study 15-2011-15064_cells_found.504133.fcs	082812-Mike-Study 15-2011-15064_cells_found.fcs
SUB134293	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		29.4	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741033			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805039	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134293	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		29.4	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741033			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805039	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504134	CyTOF result	082812-Mike-Study 15-2011-15065_cells_found.504134.fcs	082812-Mike-Study 15-2011-15065_cells_found.fcs
SUB134294	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		78	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741034			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805040	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134294	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		78	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741034			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805040	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504135	CyTOF result	082812-Mike-Study 15-2011-15066_cells_found.504135.fcs	082812-Mike-Study 15-2011-15066_cells_found.fcs
SUB134295	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741035			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805041	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134295	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741035			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805041	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504136	CyTOF result	090512-Study 15-2011-15067_cells_found.504136.fcs	090512-Study 15-2011-15067_cells_found.fcs
SUB134296	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741036			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805042	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134296	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741036			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805042	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504137	CyTOF result	090512-Study 15-2011-15068_cells_found.504137.fcs	090512-Study 15-2011-15068_cells_found.fcs
SUB134297	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		74.6	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741037			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805043	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134297	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		74.6	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741037			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805043	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504138	CyTOF result	090712-Mike-Study 15-2011-15069_cells_found.504138.fcs	090712-Mike-Study 15-2011-15069_cells_found.fcs
SUB134298	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		80.5	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741038			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805044	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134298	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		80.5	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741038			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805044	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504139	CyTOF result	090512-Study 15-2011-15070_cells_found.504139.fcs	090512-Study 15-2011-15070_cells_found.fcs
SUB134299	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741039			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805045	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134299	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741039			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805045	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504140	CyTOF result	082812-Mike-Study 15-2011-15071_cells_found.504140.fcs	082812-Mike-Study 15-2011-15071_cells_found.fcs
SUB134300	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		64.7	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741040			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805046	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134300	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		64.7	Years	Non-twin	ARM643	Group B	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741040			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805046	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504141	CyTOF result	082812-Mike-Study 15-2011-15072_cells_found.504141.fcs	082812-Mike-Study 15-2011-15072_cells_found.fcs
SUB134301	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741041			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805047	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134301	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741041			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805047	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504142	CyTOF result	082812-Mike-Study 15-2011-15073_cells_found.504142.fcs	082812-Mike-Study 15-2011-15073_cells_found.fcs
SUB134303	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		28.6	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741042			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805048	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134303	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		28.6	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741042			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805048	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504143	CyTOF result	082812-Mike-Study 15-2011-15075_cells_found.504143.fcs	082812-Mike-Study 15-2011-15075_cells_found.fcs
SUB134304	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at Study Day 0		27.5	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741043			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805049	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134304	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at Study Day 0		27.5	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741043			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805049	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504144	CyTOF result	082812-Mike-Study 15-2011-15076_cells_found.504144.fcs	082812-Mike-Study 15-2011-15076_cells_found.fcs
SUB134307	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		28.5	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741044			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805050	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134307	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		28.5	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741044			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805050	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504145	CyTOF result	082812-Mike-Study 15-2011-15079_cells_found.504145.fcs	082812-Mike-Study 15-2011-15079_cells_found.fcs
SUB134308	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741045			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805051	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134308	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741045			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805051	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504146	CyTOF result	082812-Mike-Study 15-2011-15080_cells_found.504146.fcs	082812-Mike-Study 15-2011-15080_cells_found.fcs
SUB134312	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741046			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805052	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134312	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		90	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741046			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805052	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504147	CyTOF result	082812-Mike-Study 15-2011-15084_cells_found.504147.fcs	082812-Mike-Study 15-2011-15084_cells_found.fcs
SUB134317	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		85	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741047			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805053	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134317	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		85	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741047			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805053	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504148	CyTOF result	082812-Mike-Study 15-2011-15089_cells_found.504148.fcs	082812-Mike-Study 15-2011-15089_cells_found.fcs
SUB134318	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at Study Day 0		32.1	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741048			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805054	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134318	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at Study Day 0		32.1	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741048			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805054	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504149	CyTOF result	082812-Mike-Study 15-2011-15090_cells_found.504149.fcs	082812-Mike-Study 15-2011-15090_cells_found.fcs
SUB134320	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		30.2	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741049			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805055	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134320	Homo sapiens	White		Not Hispanic or Latino		Male	Age at Study Day 0		30.2	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741049			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805055	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504150	CyTOF result	090512-Study 15-2011-15092_cells_found.504150.fcs	090512-Study 15-2011-15092_cells_found.fcs
SUB134322	Homo sapiens	Other	White, Asian	Not Hispanic or Latino		Female	Age at Study Day 0		31.1	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741050			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805056	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134322	Homo sapiens	Other	White, Asian	Not Hispanic or Latino		Female	Age at Study Day 0		31.1	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741050			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805056	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504151	CyTOF result	083012-Mike-Study 15-2011-V1-15094_cells_found.504151.fcs	083012-Mike-Study 15-2011-V1-15094_cells_found.fcs
SUB134323	Homo sapiens	Other	Middle Eastern	Not Hispanic or Latino		Female	Age at Study Day 0		26.8	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741051			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805057	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134323	Homo sapiens	Other	Middle Eastern	Not Hispanic or Latino		Female	Age at Study Day 0		26.8	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741051			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805057	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504152	CyTOF result	083012-Mike-Study 15-2011-V1-15095_cells_found.504152.fcs	083012-Mike-Study 15-2011-V1-15095_cells_found.fcs
SUB134324	Homo sapiens	Other	White, Asian	Not Hispanic or Latino		Male	Age at Study Day 0		23.8	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741052			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805058	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134324	Homo sapiens	Other	White, Asian	Not Hispanic or Latino		Male	Age at Study Day 0		23.8	Years	Non-twin	ARM642	Group A	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741052			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805058	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504153	CyTOF result	082812-Mike-Study 15-2011-15096_cells_found.504153.fcs	082812-Mike-Study 15-2011-15096_cells_found.fcs
SUB134325	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		87.1	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741053			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805059	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB134325	Homo sapiens	White		Not Hispanic or Latino		Female	Age at Study Day 0		87.1	Years	Non-twin	ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741053			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805059	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504154	CyTOF result	082812-Mike-Study 15-2011-15097_cells_found.504154.fcs	082812-Mike-Study 15-2011-15097_cells_found.fcs
SUB207076	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years		ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741056			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805062	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504090	CyTOF result	Study 15-2011-V1.504090.xml	Study 15-2011-V1.xml
SUB207076	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years		ARM644	Group C	SDY112	T cell responses to H1N1v and a longitudinal study of seasonal influenza vaccination (TIV) SLVP015 2011 (See companion studies SDY311 2010 / SDY312 2009 / SDY314 2008 / SDY315 2012)	BS741056			PBMC		0	Days	Time of initial vaccine administration			PV1950	V1 : Primary vaccination	EXP13804	ES805062	PBMCs day 0	OTHER	No Treatment	ESR11648, ESR11652, ESR11653, ESR11654, ESR11655, ESR11656, ESR11657, ESR11658, ESR11659, ESR11661, ESR11662, ESR11665, ESR11666, ESR11667, ESR11669, ESR11670, ESR11672, ESR11675, ESR11677, ESR11679, ESR11719, ESR11723, ESR11724, ESR11725, ESR11726, ESR11727, ESR11728, ESR11729, ESR11730, ESR11732, ESR11735, ESR11736, ESR11737, ESR11738, ESR11740, ESR11742, ESR11743, ESR11746, ESR11748, ESR11750, ESR13852, ESR13853, ESR13854, ESR13855, ESR13856, ESR13857	CCR7 antibody-unconjugated, CD127 antibody-unconjugated, CD14 antibody-unconjugated, CD16 antibody-unconjugated, CD161 antibody-unconjugated, CD19 antibody-unconjugated, CD20 antibody-unconjugated, CD24 antibody-unconjugated, CD25 antibody-unconjugated, CD28 antibody-unconjugated, CD3 antibody-unconjugated, CD4 antibody-unconjugated, CD45RA antibody-unconjugated, CD56 antibody-unconjugated, CD8 antibody-unconjugated, CD85j antibody-unconjugated, CD94 antibody-unconjugated, HLADR antibody-unconjugated, IgD antibody-unconjugated, TCRgd antibody-unconjugated, CCR7-Gd160, CD127-Ho165, CD14-Sm154, CD161-Er170, CD16-Sm149, CD19-Nd142, CD20-Dy164, CD24-Er168, CD25-Yb176, CD28-Er167, CD3-Nd150, CD45RA-Dy162, CD4-Nd143, CD56-Yb174, CD85j-Sm147, CD8-Nd144, CD94-Gd156, HLADR-Lu175, IgD-Nd146, TCRgd-Yb171, anti-CD38, anti-CD27, anti-CD33, anti-CD38, anti-CD27, anti-CD33	NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, NA, Gd160, Ho165, Sm154, Er170, Sm149, Nd142, Dy164, Er168, Yb176, Er167, Nd150, Dy162, Nd143, Yb174, Sm147, Nd144, Gd156, Lu175, Nd146, Yb171, NA, NA, NA, Eu151, Sm152, Er166	504157	CyTOF result	082812-Mike-Study 15-2011-15101_cells_found.504157.fcs	082812-Mike-Study 15-2011-15101_cells_found.fcs
